Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. David Bates

General Internal Medicine · BWH

View

Dr. Reema Dbouk

Obesity Medicine · Emory University

View

Dr. Jennifer Paisley

Obesity Medicine · St. Elizabeth Medical Center

View

Dr. Molly Heublein

Primary Care · Clear Medical Clinic

View

Dr. Ryan Mire

Primary Care · Heritage Medical Associates

View

Dr. Alpesh Amin

Hospital Medicine · UCI

View

Dr. Joia Mukherjee

Global Health · Harvard Medical School

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials

    Sep 9, 2026DOI: 10.1056/nejmoa2601598Original ArticleNEJM

    Written by: Yves Dauvilliers, M.D.Emmanuel Mignot, M.D.Jakub Antczak, M.D.Isabelle Arnulf, M.D.Lucie Barateau, M.D.Erik Buntinx, M.D.Bruce Corser, M.D.Alex Iranzo, M.D., Ph.D.Ramin Khatami, M.D.Gert Jan Lammers, M.D.Katharina Lederer, M.D.Kristian Bernhard Nilsen, M.D., Ph.D.Fabio Pizza, M.D.Markus H. Schmidt, M.D.Sheila Sivam, M.D., Ph.D.Oliver Sum-Ping, M.D.Mitsutaka Taniguchi, M.D.Shuqin Zhan, M.D.Anson Abraham, Ph.D.Alice Cai, M.D.Yeting Du, Ph.D.Mark R. Etherton, M.D., Ph.D.Helene Faessel, Pharm.D, Ph.D.Samuel Hsiao, Ph.D.Harisha Kadali, M.D.Elena Koundourakis, Ph.D.Melissa Naylor, M.D., Ph.D.Rachel Neuwirth, M.S.Tina Olsson, Ph.D.Raquel Rogers, M.D.Sarah Sheikh, B.M., B.Ch.Shinichiro Tanaka, Ph.D.Philipp von Rosenstiel, M.D.Christian von Hehn, M.D., Ph.D.Yaming Hang, Ph.D.Baiyun Yao, Ph.D.Rafael del Rio Villegas, M.D., Ph.D.Giuseppe Plazzi, M.D.

    Find these authors on Roon

    BC
    Dr. Bruce Corser
    Sleep Medicine · Intrepid Research

    Summary

    In two placebo-controlled trials, oveporexton improved wakefulness, reduced daytime sleepiness, and lowered the cataplexy rate among patients with narcolepsy type 1. Increased urinary frequency and transient insomnia were common.
    BCDr. Bruce Corser

    Dr. Bruce Corser

    Internal Medicine · Sleep Medicine
    Intrepid Research
    brucec